Brief: Day One Reports Second Quarter 2022 Financial Results And Corporate Progress

Day One Biopharmaceuticals

04/08/2022 22:27

Aug 4 (Reuters) - Day One Biopharmaceuticals Inc  DAWN.O :
    * DAY ONE REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
CORPORATE PROGRESS
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.60
    * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED
$394.9
MILLION ON JUNE 30, 2022
    * Q2 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3dP448 
Further company coverage:  DAWN.O 

 ((Reuters.Briefs@thomsonreuters.com;))